Table 1 from The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial
Year: 2026
Type: other
Abstract: Number of grade 3–5 treatment-relateda acuteb AEs by KRAS and assigned treatment.
Authors: Joanne B. Weidhaas, Jonathan Harris, Maura L. Gillison, Dukagjin Blakaj, Greg A. Krempl, Kristin Higgins, Jack Phan, Neal E. Dunlap, Shazia T. Mahamood, Jennifer Dorth, Jimmy J. Caudell, Anand B. Desai, Thomas J. Galloway, J. Daniel Pennington, Adam Currey, Jennifer Lathrop, Pedro A. Torres-Saavedra, D. Neil Hayes, Sue S. Yom, Quynh-Thu Le
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7143765262